Back to Results
First PageMeta Content
Private equity / Venture capital / Business Development Bank of Canada / Collective investment scheme / Financial economics / Investment / Finance


FOR IMMEDIATE RELEASE Xagenic Announces Second Closing of $25.5M Series B Financing Toronto, ON (July 14, 2014) – Xagenic Inc., a molecular diagnostics company developing the first labfree molecular diagnostic platfor
Add to Reading List

Document Date: 2014-08-18 16:56:02

Open Document

File Size: 114,01 KB

Share Result on Facebook

City

Montreal / Toronto / San Diego / /

Company

Amgen / Amylin Pharmaceuticals / Ontario Capital Growth Corporation / The Ontario Emerging Technologies Fund / Xagenic Inc. / Dura Pharmaceuticals / Domain Associates L.L.C. / BDC Capital / CTI Life Sciences Fund / /

Country

Canada / /

Currency

USD / /

/

Event

Funding / Product Release / Employment Change / /

IndustryTerm

venture capital / clean technology / biotechnology / industrial/clean/energy technology / healthcare investing / start-up / communications technology / healthcare / health technologies / pharmaceuticals / digital media / pharmaceutical industries / investment solutions / /

MedicalCondition

disease / /

Organization

Bank of Canada / Ontario Emerging Technologies Fund / Ministry of Economic Development and Innovation / /

Person

Dion Madsen / Jesse Treu / Shana Kelley / Bruce Cohen / /

/

Position

CTO / Executive Chairman / physician / private Ontario companies / Managing Partner / Chief Technology Officer / Governor / Representative / board member / /

Product

Series B / /

ProvinceOrState

New Jersey / Ontario / /

Technology

industrial/clean/energy technology / biotechnology / communications technology / health technologies / /

URL

www.bdccapital.ca / http /

SocialTag